Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

MoonLake Immunotherapeutics (MLTX) Net Income (2021 - 2026)

MoonLake Immunotherapeutics' Net Income history spans 6 years, with the latest figure at -$69.7 million for Q1 2026.

  • Quarterly Net Income fell 71.87% to -$69.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$259.5 million through Mar 2026, down 75.52% year-over-year, with the annual reading at -$230.3 million for FY2025, 89.96% down from the prior year.
  • Net Income came in at -$69.7 million for Q1 2026, down from -$63.0 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of -$7.9 million in Q4 2023 to a low of -$70.7 million in Q3 2025.
  • The 5-year median for Net Income is -$17.4 million (2022), against an average of -$31.2 million.
  • The largest YoY upside for Net Income was 69.3% in 2022 against a maximum downside of 20715.22% in 2022.
  • MoonLake Immunotherapeutics' Net Income stood at -$16.5 million in 2022, then soared by 52.11% to -$7.9 million in 2023, then tumbled by 488.23% to -$46.4 million in 2024, then crashed by 35.83% to -$63.0 million in 2025, then fell by 10.61% to -$69.7 million in 2026.
  • Per Business Quant, the three most recent readings for MLTX's Net Income are -$69.7 million (Q1 2026), -$63.0 million (Q4 2025), and -$70.7 million (Q3 2025).